News & Articles

Interim data shows strong antibody and T-cell responses in all evaluated participants

Company also receives new FDA emergency use authorizations for use of self-collection molecular diagnostic kit on the Hologic and Roche platforms

xMAP SARS-CoV-2 Multi-Antigen IgG Assay is enabled by xMAP Technology, the gold standard for multiplexing serologic testing

Cambridge researchers have shown how rapid genome sequencing of virus samples and enhanced testing of hospital staff can help to identify clusters of healthcare-associated COVID-19 infections

Faster, more accurate diagnoses are critical with non-small cell lung cancer, which accounts for about 85 percent of all lung cancer cases

The bridging assay aims to allow a full-length trimeric Spike protein from the COVID-19 virus to be used as both a capture and detection tool

From Monday, July 20: Join world-leading clinical scientists and healthcare professionals online - free to attend

The agreement allows First Genetics to bring its F-Genetics NGS system and in vitro diagnostic assays for reproductive health testing to Russian labs

The partnership aims to bring access to Twist's proprietary phage display libraries for the discovery of antibodies in Takeda's biologics pipeline

Delivers major improvements for discoveries in immunology, oncology, autoimmunity, and infectious diseases

Patented PrimeStore MTM technology is designed to enable safe sample handling and testing for multiple pathogens from one sample swab

Dr. Emma Walker reveals how transitioning from immunoassays to LC-MS/MS has helped deliver better diagnostic services in her lab

Partnership to evaluate the use of Affimer reagents to detect the coronavirus using novel sensors

Find out about the 'revolutionary' technology enabling one lab to provide higher-quality, more timely data for cancer researchers

Collaboration combines innovative plant-based and adjuvant technologies to develop and produce a COVID-19 candidate vaccine

The strategic partnership aims to catapult COVID-19 diagnostic testing capacity well ahead of the significant demand

Dr. Dennis Nurjadi discusses the cell counting technology that has brought his team accuracy and reproducibility